Brief: Nuvasive Inc - Received 510(K) Clearance From FDA For Use Of Its Modulus Cervical Interbody Implant With A Bone Void Filler
Feb 21 (Reuters) - NuVasive Inc NUVA.O :
* NUVASIVE INC - RECEIVED 510(K) CLEARANCE FROM FDA FOR USE
OF ITS
MODULUS CERVICAL INTERBODY IMPLANT WITH A BONE VOID FILLER
Source text for Eikon: ID:nPnc313R5a
Further company coverage: NUVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NuVasive
See all newsJackson Financial to join small-cap S&P 600; shares climb
NuVasive Inc reports results for the quarter ended in June - Earnings Summary
Brief: NuVasive Q2 Adjusted EPS USD 0.56 Vs. IBES Estimate USD 0.55
NuVasive Inc expected to post earnings of 55 cents a share - Earnings Preview
Brief: NuVasive Borrows $350 Mln In Revolving Loans Under 2020 Facility